Actively Recruiting

Phase 4
Age: 75Years +
All Genders
NCT05361421

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

Led by Yonsei University · Updated on 2024-03-15

1200

Participants Needed

1

Research Sites

273 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Although there have been studies regarding intensive lowering of low-density lipoprotein (LDL)-cholesterol with high intensity statins in patients with cardiovascular disease, elderly patients were either excluded or accounted only a small portion of study subjects. Therefore, this study sought to compare the clinical outcomes according to the LDL-cholesterol therapy targeting (intensive targeting \[LDL-cholesterol \<55mg/dL\] vs. conventional therapy \[moderate intensity statin therapy\]) in elderly patients with ≥75 years and documented cardiovascular disease.

CONDITIONS

Official Title

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

Who Can Participate

Age: 75Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 75 years or older
  • Documented cardiovascular disease including at least one of the following: previous acute coronary syndrome (heart attack or unstable angina), stable angina confirmed by imaging or functional tests, coronary revascularization, or peripheral artery disease
Not Eligible

You will not qualify if you...

  • Heart attack or stroke within the past year
  • LDL-cholesterol level less than 55 mg/dL without statin therapy
  • Active liver disease or persistent unexplained liver enzyme elevation more than twice the upper normal limit
  • Allergy or hypersensitivity to any statin
  • Life expectancy less than 1 year
  • Inability to follow the patient for at least 1 year after enrollment as assessed by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Yonsei University Health System, Severance Hospital

Seoul, South Korea

Actively Recruiting

Loading map...

Research Team

B

Byeong-Keuk Kim

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here